Given a document and an entity the task is to select the author's sentiment towards the entity. Sentiments can be Positive, Neutral and Negative. Select Positive if the article expresses a positive view towards the given entity or praises its quality or skills. Select Neutral if the document expresses no clear view towards the entity or has equal amounts of positive and negative statements or expressing some fact/quote by someone else. Select Negative if the article expresses a negative view towards like harsh remarks, criticizing entities action/decision etc. Note that URLs in the text have been replaced with [Link].

Ex Input:
What is the sentiment of the following document towards the entity Fadia ? So once again  we put out the call to Syrian contacts around the U.S. And we found  a woman named Fadia .  She  was born and raised in Aleppo and came to the U.S. more than 30 years ago.  She  and  her  husband raised their children here.  She  asked that we not use  her  last name because  she  still has family in Aleppo and doesn't want them to get in trouble if the wrong person hears of  her  participation in this story.
But  her  family â they were our in.
So that's how it happened that one of Fadia's relatives walked in to Syrjeia by the public garden and said  "There's a radio show in New York that wants to talk to you."
A few weeks later  I was in  Fadia 's living room in the New York suburbs calling Imad Syrjeia on an app called Viber that the Syrian government can't track. Imad's father opened the restaurant in the 1970s and has since passed away.
At first  Imad was wary.  Fadia  explained  her  family's connection to  his  and reminded  him  of the person who had come into  his  store talking about a radio show in New York.  She  said it's just a show about food â nothing political.  He  said OK.
When I asked how  he  and the restaurant were doing  Imad insisted everything was great. But  Fadia  said  he  would never dare say otherwise  in case the wrong person is listening.
" He  doesn't know you " she explains. " He  can't even say it to  me . I'm Syrian but  he  won't."
I don't speak Arabic. (Later on I had the recording of this conversation translated.) But just hearing Imad's voice coming out of the speaker in that moment was deeply moving. Knowing  his  voice was coming from a place that the news had told me was destroyed.
As  Fadia  and I said goodbye to him  he invited me to Syria.
"He will welcome you " said  Fadia  enthusiastically. "They're very generous. They welcome everybody!"

Ex Output:
Positive


Ex Input:
What is the sentiment of the following document towards the entity Ablynx ? PARIS/LONDON (Reuters) - French drugmaker Sanofi has agreed to buy  Belgian biotech company Ablynx  for 3.9 billion euros ($4.8 billion)  beating Novo Nordisk and marking its second big deal this month after buying Bioverativ.
The deal is a further sign of accelerating merger and acquisition (M&A) activity in the global biotech sector and comes after  Ablynx  rejected a 2.6 billion euro offer from Denmark’s Novo Nordisk.
Sanofi said on Monday it would pay 45 euros per share in cash for Ablynx  a premium of 21 percent over its closing price on Friday - and more than double the price before Novo went public with its initial bid.
Novo Nordisk conceded defeat  saying it did not intend to make a revised offer for Ablynx  which is developing a prized experimental drug for a rare blood disorder.
Sanofi said  Ablynx  would boost long-term value for  its  shareholders  while the takeover was expected to have a neutral impact on Sanofi’s business earnings per share (EPS) in 2018 and 2019.
Sanofi is already one of  Ablynx ’s big pharma partners  after striking a deal in July 2017 to find new treatments for inflammatory diseases.
By buying the company outright it will now get access to  Ablynx ’s most promising asset  the experimental drug caplacizumab for treating the rare bleeding disorder acquired thrombotic thrombocytopenic purpura.
Sanofi will be able to use its existing infrastructure and the recently acquired platform from Bioverativ to help to commercialize caplacizumab. It will also benefit from some of the other drugs  Ablynx  is working on  such as an infant anti-viral treatment  that would not have fitted within Novo Nordisk.
Berenberg analysts said  Ablynx  was a good fit but they estimated the deal would generate no more than a 4 percent return on invested capital  assuming caplacizumab sales of around 400 million euros by 2023.
The Danish group has sat out previous rounds of M&A in the drugs sector to focus on its core diabetes business but it now needs to find new products for its struggling smaller biopharmaceutical unit  where Ablynx would have been a good fit.
Morgan Stanley and Lazard advised Sanofi on the deal while JP Morgan advised Ablynx.

Ex Output:
Positive


Ex Input:
What is the sentiment of the following document towards the entity Desmond Tutu ? Here's a look at the life of Nobel Peace Prize winner Archbishop Desmond Tutu.
1998 - Establishes the Desmond Tutu Peace Trust.
September 30  2007 -  Tutu  leads The Elders on their first mission  to Darfur in  Tutu  leads The Elders on their first mission  to Darfur in Sudan.
October 2011 -  Tutu  harshly criticizes the South African government for failing to issue a visa to  the Tutu  harshly criticizes the South African government for failing to issue a visa to the Dalai Lama.  He  accuses the government of pandering to China and in some ways being worse than the apartheid-era governments.
October 3  2011 - "Tutu: The Authorised Portrait" is released to coincide with Tutu's "Tutu: The Authorised Portrait" is released to coincide with  Tutu 's 80th birthday. The book  written by his daughter Mpho and Allister Sparks  contains personal writings as well as anecdotes by people including Richard Branson  Bono  the Dalai Lama  Mandela and others.
October 4  2012 -  Tutu  is  Tutu  is awarded $1 million by the Mo Ibrahim Foundation for " his  lifelong commitment to speaking truth to power."
April 4  2013 -  Tutu  is awarded the 2013 Templeton Prize for  his   Tutu  is awarded the 2013 Templeton Prize for  his  "life-long work in advancing spiritual principles such as love and forgiveness which has helped to liberate people around the world." The prize is worth about $1.7 million dollars.
April 24-29  2013 -  Tutu  is hospitalized to undergo tests for a persistent infection  according to  his  foundation.
July 14-21  2015 - Tutu is admitted to a Cape Town  South Africa  hospital to be  Tutu  is admitted to a Cape Town  South Africa  hospital to be treated for a persistent infection.
August 24  2016 -  Tutu  admits  himself  to a Cape Town hospital to be treated for a recurring infection.  Tutu  admits  himself  to a Cape Town hospital to be treated for a recurring infection.
September 7  2016 - Tutu undergoes surgery to address recurring infections affecting  his  health.
September 17-21  2016 -  Tutu  is readmitted to a South African hospital after  he  shows signs of infection following  his  recent surgery.  Tutu  is readmitted to a South African hospital after  he  shows signs of infection following  his  recent surgery.
October 6  2016 - The day before  his  85th birthday   he  writes a Washington Post article supporting the right to die with dignity. "Dying people should have the right to choose how and when they leave Mother Earth. I believe that  alongside the wonderful palliative care that exists  their choices should include a dignified assisted death."

Ex Output:

Neutral